2021 Results and Financial Review

Footnotes (1) The estimated Solvency II position represents the shareholder view only £3.75bn B Share Scheme (subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position) in addition to existing £1bn share buyback Slide Reference Footnote 1. 7 2. 1. From continuing operations 8 2. Gross written premiums 3. 1. 9 2. 1. 10 2. 11 1. Controllable costs excluding IFRS 17 & implementation costs Subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position. There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposal Settlement of B Share Scheme for American Depositary Share holders expected to take place in early June 2022 There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposals. Illustrative dividends are subject to change. The Board has not approved or made any decision to pay any dividend in respect of any future period. The 2022 and 2023 DPS figures have been calculated to show the estimated dividend per share following the share consolidation using an illustrative consolidation ratio The estimated Solvency II position represents the shareholder view only Subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position. There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposal Cash remittances and SII own funds generation targets are expressed after £300m cost of growth initiative and £200m cost of efficiency initiatives. Cost reduction target excludes both of these items Controllable costs excluding IFRS 17, implementation costs and planned investment in growth 1. 2. 12 3. Gross of inflation 4. Net of inflation 1. 2. 14 3. 4. 15 1. From continuing operations References to sales represent present value of new business premiums (PVNBP) The estimated Solvency II position represents the shareholder view only Controllable costs excluding IFRS 17 & implementation costs Centre costs exclude £300m of Group funded growth and efficiency initiatives incurred across the 3 years 2022-24 1. The estimated Solvency II position represents the shareholder view only 16 نم Subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position. There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposals AVIVA 64

View entire presentation